Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients

Dysregulation of immune response was observed in COVID-19 patients. Thymosin alpha 1 (Tα1) is used in the management of COVID-19, because it is known to restore the homeostasis of the immune system during infections and cancers. We aim to observe the longitudinal changes in T lymphocyte subsets and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhenyan, Chen, Jun, Zhu, Cuiyun, Liu, Li, Qi, Tangkai, Shen, Yinzhong, Zhang, Yuyi, Xu, Lie, Li, Tao, Qian, Zhiping, Steinhart, Corklin R., Lu, Hongzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209490/
https://www.ncbi.nlm.nih.gov/pubmed/34149679
http://dx.doi.org/10.3389/fimmu.2021.568789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209490/
https://www.ncbi.nlm.nih.gov/pubmed/34149679
http://dx.doi.org/10.3389/fimmu.2021.568789

Ejemplares similares